Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo.

about

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo.

Item

http://www.wikidata.org/entity/Q52592855

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@en

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@nl

type

Item

label

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@en

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@nl

prefLabel

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@en

Pomalidomide enhanced gemcitab ...... cer both in vitro and in vivo.

@nl

P1476

Pomalidomide enhanced gemcitab ...... ncer both in vitro and in vivo

@en

P2093

Hiroaki Shiba

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sugano

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Yanaga

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Saito

http://www.w3.org/2001/XMLSchema#string

Tadashi Uwagawa

http://www.w3.org/2001/XMLSchema#string

Takashi Horiuchi

http://www.w3.org/2001/XMLSchema#string

Toya Ohashi

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Shirai

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

Stretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes.

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

P304

15780-15791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24608

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koichiro Haruki

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29644009

http://www.w3.org/2001/XMLSchema#string

P932

5884664

http://www.w3.org/2001/XMLSchema#string